Labiano, Prince .

HRN: 28-80-54  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2026
CEFTRIAXONE 1G (VIAL)
04/07/2026
04/14/2026
IV
250mg
Q12h
PCAP-C; R/O CNSI
Checking Initial Appropriateness 
04/09/2026
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
04/09/2026
04/14/2026
PO
1.3ml
OD
PCAP-C
Checking Initial Appropriateness 
04/09/2026
MUPIROCIN 2%, 15G (TUBE)
04/09/2026
04/16/2026
TOPICAL
As Needed
TID
Phlebitis
Checking Initial Appropriateness 
04/09/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/09/2026
04/16/2026
IV
500mg
Q8hours
PCAP-C
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: